National and Kapodistrian University of Athens
Μελέτη της σχέσης χρόνιας διαλείπουσας υπερχολερυθριναιμίας (σύνδρομο Gilbert) και οικογενούς μεσογειακού πυρετού
Abstract
dc:descriptionFamilial Mediterrenean Fever (FMF) is a relatively common genetic disease in the Mediterrenean basin associated with one or more mutations in the MEFV gene coding for the protein pyrin. Patients with FMF commonly display elevated indirect bilirubin levels during the characteristic FMF attacks which have been attributed either to the inflammatory process itself and/or to other unknown factors (genetic, environmental). Gilbert’s syndrome (GS) is a much more common genetic disease characterized by asymptomatic elevations of unconjugated bilirubin attributed to mutations of the UGT1A1 gene coding for the enzyme UDP-glucuronosyltransferase (UGT) that is involved in bilirubin glucuronidation in hepatocytes. It is unclear if GS mutations could play a role in bilirubin elevations in FMF patients.The aims of this study was first to identify the prevalence of mutations of the MEFV gene in Greek patients with FMF and of the UGT1A1 gene in Greek patients with GS and secondly to compare the prevalence of the UGT1A1 mutations between FMF patients and healthy controls in the general Greek population.Ninety six patients with FMF (all were studied for the presence of the twelve most common MEFV mutations and 88 for the presence of UGT1A1 mutations), 28 patients with GS (all were studied for UGT1A1 mutations) and 82 healthy controls (all were studied for UGT1A1 mutations) were included in the study. Moreover, 39 patients with GS and the homozygous gene promoter configuration (TA)7/(TA)7 were studied for the presence of MEFV mutations.Among patients with FMF (n=96), the majority (n=86, 90%) displayed at least one mutation of the MEFV gene; 62 (65%) had one mutation and 24 (25%) two mutations (n=5 or 5% were homozygotes and 19 or 20% were compound heterozygotes). The most common mutation in this population was the E148Q (19.8%). The characteristic homozygous configuration (TA)7/(TA)7 was present in 61% of patients with GS, 13% of healthy controls and 14% of FMF patients (p=NS between FMF patients and healthy controls). Interestingly among patients with FMF and no mutations (n=10), none had this configuration. Moreover, among the 39 patients with GS and the (TA)7/(TA)7 configuration, none had MEFV gene mutations.In conclusion, these results provide novel information regarding the prevalence of MEFV and UGT1A1 gene mutations in Greek patients with FMF and GS, respectively. Specifically, it was found that the vast majority of FMF patients (90%) demonstrate at least one mutation of the MEFV gene while the characteristic (TA)7/(TA)7 configuration was present in approximately 60% of GS patients. Although the prevalence of the (TA)7/(TA)7 configuration was not different between FMF patients and healthy controls, it is interesting that none of the GS patients with this configuration had MEFV gene mutations. More studies are needed in order to explore the role of UGT1A1 gene mutations in the clinical course of FMF as well as its effect in the emergence of MEFV gene mutations.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Antonatou, Katerina
- Αντωνάτου, Κατερίνα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40784